Financial Performance - The company's operating revenue for Q1 2025 was CNY 49,506,666.59, a decrease of 1.23% compared to CNY 50,124,898.01 in the same period last year[5] - Net profit attributable to shareholders increased by 19.05% to CNY 1,724,423.28 from CNY 1,448,496.25 year-on-year[5] - The company reported a net profit of 2,030,130.07, an increase of 26.94% compared to the previous period[12] - Operating profit reached 2,545,698.57, reflecting a growth of 123.81% year-over-year[12] - Total profit amounted to 2,587,541.82, which is a 58.16% increase from the last reporting period[12] - Basic and diluted earnings per share improved to CNY 0.0057 from CNY 0.0048, reflecting better profitability[26] Cash Flow and Assets - The net cash flow from operating activities rose significantly by 104.47% to CNY 21,741,899.23 compared to CNY 10,633,328.62 in the previous year[5] - Cash and cash equivalents increased by 28.49% to CNY 113,537,459.01 from CNY 88,362,350.75 at the beginning of the year[11] - The company experienced a significant increase in cash inflows from operating activities, totaling CNY 106,603,827.06 compared to CNY 74,516,259.60 in the previous period[29] - As of March 31, 2025, the total assets of the company amounted to CNY 957,246,282.05, an increase from CNY 948,323,357.76 at the beginning of the period[24] - Accounts receivable decreased by 15.61% to CNY 186,945,861.99 from CNY 221,515,894.00 at the beginning of the year[11] Costs and Expenses - The company reported a gross profit margin of 36.73%, an increase of 7.17 percentage points from the previous year, driven by a decrease in raw material prices[9] - Total operating costs increased to CNY 58,300,473.64 from CNY 57,733,809.35, with operating costs specifically rising from CNY 35,303,767.47 to CNY 31,321,004.38[25] - Research and development expenses for the period were CNY 5,747,722.73, a decrease of 5.61% compared to CNY 6,089,171.92 in the previous year[11] - Research and development expenses decreased slightly to CNY 5,747,722.73 from CNY 6,089,171.92, indicating a focus on cost management[25] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 17,577[14] - The largest shareholder,航膜科技发展集团有限公司, holds 23.63% of the shares, totaling 71,372,565 shares[14] - The shareholder 华益科技国际 (British Virgin Islands) plans to reduce its stake by up to 3,020,000 shares, representing 1% of the total share capital[19] Corporate Developments - The company appointed Mr. Fan Ning as the General Manager and Mr. Lv Xiaolong as the Chief Scientist during the second meeting of the fifth board of directors[20] - The company completed the internal transfer of membrane production-related assets to its wholly-owned subsidiary Tianjin Membrane Technology Co., Ltd. as of January 1, 2025[21] - The company’s subsidiary, Hebei Jinmo New Materials Technology Co., Ltd., acquired a 34% stake in Shandong Jinmo New Materials Technology Co., Ltd. for a total investment of CNY 10.2 million[21] Legal and Financial Guarantees - A major lawsuit involving the company has progressed, with a court ruling in favor of the company, leading to partial recovery of funds[18] - The company plans to provide guarantees for its wholly-owned subsidiaries to secure additional financing[16] Future Outlook - The company plans to continue enhancing its marketing strategies and accelerate project delivery and payment collection throughout the year[10] - The company has increased its marketing efforts and project implementation, resulting in a good growth in new orders for membrane products and systems[10] Accounting and Reporting - The first quarter report is unaudited[31] - The new accounting standards will be implemented starting in 2025[31] - The financial statement items related to the first year of implementation will be adjusted accordingly[31] - The board of directors announced the report on April 21, 2025[31]
津膜科技(300334) - 2025 Q1 - 季度财报